MedPath

The study is to compare the two groups of drugs for prevention of vomiting after surgery

Phase 3
Conditions
Health Condition 1: H661- Chronic tubotympanic suppurative otitis mediaHealth Condition 2: H673- Otitis media in diseases classified elsewhere, bilateralHealth Condition 3: H679- Otitis media in diseases classified elsewhere, unspecified ear
Registration Number
CTRI/2022/12/047871
Lead Sponsor
VIMSAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA I,II with 20 to 65yrs both male and female are selected who are posted for Middle ear surgeries

Exclusion Criteria

Pregnancy, patient with BMI >35, smokers, history of PONV/motion sickness, abnormal liver and kidney function test, patient with Diabetes and peptic ulcer are excluded from the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The incidence of PONV and rescue antiemetic requirements in granisetron and dexamethasone group is less than ondansetron and dexamethasone groupTimepoint: Time points at which variables are measured are 0hr, 2hr, 6hr, 12hr & 24hr postoperatively
Secondary Outcome Measures
NameTimeMethod
Rescue antiemetic requirements <br/ ><br>Rescue analgesic requirementsTimepoint: Within 48 hour of post-operative period
© Copyright 2025. All Rights Reserved by MedPath